Phase II study of cisplatin and vinorelbine as first-line chemotherapy in patients with carcinoma of the uterine cervix

Journal of Clinical Oncology

Volumn 17, Issue 3, 1999, Pages 756-760

  Pignata, Sandro ^a   Silvestro, Giustino ^a   Ferrari, Ettore ^a   Selvaggi, Luigi ^a   Perrone, Francesco ^a   Maffeo, Antonio ^a   Frezza, Pasquale ^a   Di Vagno, Giovanni ^a   Casella, Gennaro ^a   Ricchi, Paolo ^a   Cormio, Gennaro ^a   Gallo, Ciro ^a   Iodice, Francesco ^a   Romeo, Frank ^a   Fiorentino, Roberta ^a   Fortuna, Giovanni ^a   Tramontana, Sergio ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; NAVELBINE;

ADULT; ADVANCED CANCER; AGED; ALOPECIA; ARTICLE; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; DOSE RESPONSE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MUCOSA INFLAMMATION; NAUSEA; NEPHROTOXICITY; NEUROTOXICITY; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; PHLEBITIS; PRIORITY JOURNAL; RECURRENT CANCER; UTERINE CERVIX CARCINOMA; VOMITING;

EID: 0033016295     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/jco.1999.17.3.756     Document Type: Article

References (27)

1. Coia L, Won M, Lanciano R, et al: The pattern of care outcome study for cancer of the uterine cervix. Cancer 66:2451-2456, 1990
2. Cannistra SA, Niloff JM: Cancer of the uterine cervix. N Engl J Med 334:1030-1038, 1996
3. Petterson F: 21st annual report on the result of treatment in gynecological cancer. Int J Gynecol Obstet 36:27-130, 1991 (suppl 1)
4. Dottino PR, Plaxe SC, Beddoe A, et al: Induction chemotherapy followed by radical surgery in cervical cancer. Gynecol Oncol 39:34-39, 1990
5. Sardi J, Sananes C, Giaroli A, et al: Results of a prospective randomized trial with neoadjuvant chemotherapy in stage IB, bulky, squamous carcinoma of the cervix. Gynecol Oncol 49:156-165, 1993
6. Leone B, Vallejo C, Perez J, et al: Ifosfamide and cisplatin as neoadjuvant chemotherapy for advanced cervical carcinoma. Am J Clin Oncol 19:132-135, 1996
7. Pignata S, De Vivo R, Ricchi P, et al: Chemotherapy in squamous cell carcinoma of the cervix uteri: Present role and perspectives. Cancer Treat Rev 24:27-34, 1998
8. Bonomi P, Blessing JA, Stehman FB, et al: Randomized trial of three cisplatin dose schedules in squamous-cell carcinoma of the cervix: A Gynecologic Oncology Group study. J Clin Oncol 3:1079-1085, 1985
9. Thigpen JT, Blessing JA, DiSaia PJ, et al: A randomized comparison of a rapid versus prolonged (24 hr) infusion of cisplatin in therapy of squamous cell carcinoma of the uterine cervix: A Gynecologic Oncology Group study. Gynecol Oncol 32:198-202, 1989
10. Omura GA, Blessing JA, Vaccarello L, et al: Randomized trial of cisplatinum versus cisplatinum plus mitolactol versus cisplatinum plus ifosfamide in advanced squamous carcinoma of the cervix: A Gynecologic Oncology Group Study. J Clin Oncol 15:165-171, 1997
11. Vermoken JB, Zanetta G, De Oliveira CF, et al: Cisplatin-based combination Chemotherapy (BEMP) versus single agent cisplatin in disseminated squamous cell carcinoma of the uterine cervix (SCCUC): Mature data EORTC protocol 55863. Ann Oncol 7:318, 1996 (suppl 5) (abstr)
12. Leveque D, Jehl F: Clinical pharmokinetics of vinorelbine. Clin Pharmacokinet 31:184-197, 1996 (suppl 3)
13. Lacava JA, Leone BA, Machiavelli M, et al: Vinorelbine as neoadjuvant chemotherapy in advanced cervical carcinoma. J Clin Oncol 15:604-609, 1997
14. Morris M, Brader KR, Levenback C, et al: Phase II study of vinorelbine in advanced and recurrent squamous cell carcinoma of the cervix. J Clin Oncol 16:1094-1098, 1998
15. Le Chevalier T, Brisgand D, Douillard JY, et al: Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: Results of a European multicenter trial including 612 patients. J Clin Oncol 12:360-367, 1994
16. Wozniak AJ, Crowley JJ, Balcerzak SP, et al: Randomized phase III trial of cisplatin (CDDP) vs CDDP plus navelbine (NVB) in treatment of advanced non-small-cell lung cancer: report of a Southwest Oncology Group study (SWOG-9308). Proc Am Soc Clin Oncol 15:A1110, 1996 (abstr)
17. Furuse K, Kubota K, Kawara M, et al: Phase II study of vinorelbine in heavily previously treated small cell lung cancer. Oncology 53:169-172, 1996 (suppl 2)
18. Baietta E, Di Leo A, Biganzoli L, et al: Phase II study of vinorelbine in patients with pretreated advanced ovarian cancer: Activity in platinum-resistant disease. J Clin Oncol 14:2546-2551, 1996 (suppl 9)
19. Miller AB, Hoogstraten B, Staquet M, et al: Reporting results of cancer treatment. Cancer 47:207-214, 1981
20. Simon R: Optimal two-stage designs for phase II clinical trials. Control Clin Trials 10:1-10, 1989
21. Panici PB, Scambia G, Baiocchi G, et al: Neoadjuvant chemotherapy and radical surgery in locally advanced cervical cancer. Cancer 15:372-379, 1990
22. Buxton EJ, Meanwell CA, Hilton C, et al: Combination bleomycin, ifosfamide, and cisplatin chemotherapy in cervical cancer. J Natl Cancer Inst 81:359-361, 1989
23. Hoskin PJ, Blake PR: Cisplatin, methotrexate and bleomycin for carcinoma of the cervix: The influence of presentation and previous treatment upon response. Int J Gynecol Cancer 1:75-80, 1991
24. Papadimitriou CA, Dimopoulos MA, Giannakoulis N, et al: A phase II trial of methotrexate, vinblastine, doxorubicin, and cisplatin in the treatment of metastatic carcinoma of the uterine cervix. Cancer 15:2391-2395, 1997
25. Tattersall MHN, Ramirez C, Coppleson M: A randomized trial comparing platinum-based chemotherapy followed by radiotherapy vs. radiotherapy alone in patients with locally advanced cervical cancer. Int J Gynecol Cancer 2:244-251, 1992
26. Tattersall MHN, Lorvidhaya V, Vootiprux A, et al: Randomized trial of epirubicin and cisplatin chemotherapy followed by pelvic radiation in locally advanced cervical cancer. J Clin Oncol 13:444-451, 1995
27. Frontini L, Candido P, Cattaneo MT, et al: Cisplatin-vinorelbine combination chemotherapy in locally advanced non-small-cell lung cancer. Tumori 82:57-60, 1996 (suppl 1)